Novavax COVID-19 vaccine approved for use in adolescents aged 12-17
Novavax COVID-19 vaccine (Nuvaxovid) has been provisionally approved by the Australian Therapeutic Goods Agency (TGA) for use in adolescents aged 12 to 17 years. The
ATAGI’s recommendations on winter COVID-19 booster doses
On 25 March 2022, ATAGI recommended an additional winter booster dose (4th dose for most people) for the highest risk groups: the elderly, residents of
ATAGI flags major change for kids’ vaccines ahead of winter
ATAGI says booster shots could soon be rolled out for children aged 12-15 years as Australia ramps up its winter prep in the face of
Eligible Australian kids 16+ can now get a booster vaccine
From today, eligible Australians aged 16 and 17 years old will be able to receive a COVID-19 booster vaccine, following recommendations from the Australian Technical
TGA provisionally approves Pfizer COVID-19 vaccine for 5 to 11-year-olds
Vaccinating 5 to 11-year-old children in Australia against COVID-19 is a significant step closer, with the Therapeutic Goods Administration (TGA) provisionally approving the Comirnaty (Pfizer)
